In addition to an increased expression, some genes were also downregulated by the overexpression of FGF14, such as COL11A1 which encodes the α1 chain of collagen XI and MUC16, a well-established biomarker used to monitor the progression and recurrence of ovarian cancer [49]. This evidence concerns the gene FGF14 and ovarian carcinoma.